ATE462419T1 - Orale pharmazeutische zusammensetzung für weichkapseln mit vinorelbin und behandlungsverfahren - Google Patents

Orale pharmazeutische zusammensetzung für weichkapseln mit vinorelbin und behandlungsverfahren

Info

Publication number: ATE462419T1
Authority: AT; Austria
Prior art keywords: pharmaceutical composition; soft capsules; oral pharmaceutical; vinorelbine; vinorelbin
Prior art date: 2002-05-31

Application number

AT03731404T

Other languages

English (en)

Inventor

Joel Bougaret

Elie Leverd

Marie-Madeleine Bohn

Norbert Heintz

Original Assignee

Rp Scherer Technologies Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-31

Filing date

2003-05-28

Publication date

2010-04-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29715700&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE462419(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-05-31 Priority claimed from CA002388431A external-priority patent/CA2388431C/en

2002-05-31 Priority claimed from FR0206886A external-priority patent/FR2840203B1/fr

2002-05-31 Priority claimed from US10/161,454 external-priority patent/US6890558B2/en

2003-05-28 Application filed by Rp Scherer Technologies Llc filed Critical Rp Scherer Technologies Llc

2010-04-15 Application granted granted Critical

2010-04-15 Publication of ATE462419T1 publication Critical patent/ATE462419T1/de

Links

239000007901 soft capsule Substances 0.000 title abstract 4
GBABOYUKABKIAF-GHYRFKGUSA-N vinorelbine Chemical compound C1N(CC=2C3=CC=CC=C3NC=22)CC(CC)=C[C@H]1C[C@]2(C(=O)OC)C1=CC([C@]23[C@H]([C@]([C@H](OC(C)=O)[C@]4(CC)C=CCN([C@H]34)CC2)(O)C(=O)OC)N2C)=C2C=C1OC GBABOYUKABKIAF-GHYRFKGUSA-N 0.000 title abstract 4
238000000034 method Methods 0.000 title abstract 2
239000008203 oral pharmaceutical composition Substances 0.000 title abstract 2
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
229960002066 vinorelbine Drugs 0.000 abstract 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
239000007788 liquid Substances 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
239000008194 pharmaceutical composition Substances 0.000 abstract 2
206010028980 Neoplasm Diseases 0.000 abstract 1
239000002202 Polyethylene glycol Substances 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
201000011510 cancer Diseases 0.000 abstract 1
239000002552 dosage form Substances 0.000 abstract 1
238000005538 encapsulation Methods 0.000 abstract 1
229920001223 polyethylene glycol Polymers 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
150000003892 tartrate salts Chemical group 0.000 abstract 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

AT03731404T 2002-05-31 2003-05-28 Orale pharmazeutische zusammensetzung für weichkapseln mit vinorelbin und behandlungsverfahren ATE462419T1 (de)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
CA002388431A CA2388431C (en)	2002-05-31	2002-05-31	Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
FR0206886A FR2840203B1 (fr)	2002-05-31	2002-05-31	Composition pharmaceutique orale pour capsules molles contenant vinorelbine et methode de traitement
US10/161,454 US6890558B2 (en)	2002-05-31	2002-05-31	Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
PCT/US2003/016732 WO2003101383A2 (en)	2002-05-31	2003-05-28	Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment

Publications (1)

Publication Number	Publication Date
ATE462419T1 true ATE462419T1 (de)	2010-04-15

Family

ID=29715700

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03731404T ATE462419T1 (de)	2002-05-31	2003-05-28	Orale pharmazeutische zusammensetzung für weichkapseln mit vinorelbin und behandlungsverfahren

Country Status (14)

Country	Link
EP (1)	EP1530459B1 (de)
JP (2)	JP4718170B2 (de)
CN (1)	CN1287794C (de)
AT (1)	ATE462419T1 (de)
AU (1)	AU2003240808B2 (de)
BR (2)	BRPI0307816B8 (de)
CY (1)	CY1110184T1 (de)
DE (1)	DE60331920D1 (de)
DK (1)	DK1530459T3 (de)
ES (1)	ES2343790T3 (de)
MX (1)	MXPA04006054A (de)
PT (1)	PT1530459E (de)
SI (1)	SI1530459T1 (de)
WO (1)	WO2003101383A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9061015B2 (en) *	2004-12-30	2015-06-23	Pierre Fabre Medicament	Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it
FR2880274B1 (fr) *	2004-12-30	2007-04-13	Pierre Fabre Medicament Sa	Dispersion solide stable d'un derive d'alcaloides de vinca et son procede de fabrication
CN101134026B (zh) *	2006-08-31	2011-12-07	江苏豪森药业股份有限公司	长春瑞滨软胶囊及其制备方法和其应用
FR2918567B1 (fr) *	2007-07-11	2012-08-03	Pf Medicament	Composition pharmaceutique stable d'un sel hydrosoluble de vinorelbine.
FR2918566B1 (fr)	2007-07-11	2009-10-09	Pierre Fabre Medicament Sa	Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine.
WO2009105937A1 (zh) *	2008-02-29	2009-09-03	江苏豪森药业股份有限公司	长春瑞滨软胶囊及其制备方法和其应用
CA3014473A1 (en)	2016-03-09	2017-09-14	Synbias Pharma Ag	Vinorelbine monotartrate and its pharmaceutical use
CN121129791A (zh) *	2025-11-19	2025-12-16	人福普克药业（武汉）有限公司	一种用于抗肿瘤的软胶囊及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4623629A (en) *	1983-10-31	1986-11-18	Daniel Kerschensteiner	Solid-phase immunoassay support and method of use thereof
US5447936A (en) *	1993-12-22	1995-09-05	Bionumerik Pharmaceuticals, Inc.	Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof
US5641512A (en) *	1995-03-29	1997-06-24	The Procter & Gamble Company	Soft gelatin capsule compositions
DE19545043A1 (de) *	1995-12-02	1997-06-05	Scherer Gmbh R P	Pharmazeutische Präparate zur oralen Anwendung und Verfahren zu ihrer Herstellung
AU773061B2 (en) *	1999-05-24	2004-05-13	Southern Research Institute	Isophosphoramide mustard analogs and use thereof

2003
- 2003-05-28 MX MXPA04006054A patent/MXPA04006054A/es active IP Right Grant
- 2003-05-28 PT PT03731404T patent/PT1530459E/pt unknown
- 2003-05-28 AT AT03731404T patent/ATE462419T1/de active
- 2003-05-28 JP JP2004508741A patent/JP4718170B2/ja not_active Expired - Lifetime
- 2003-05-28 CN CNB038044390A patent/CN1287794C/zh not_active Expired - Lifetime
- 2003-05-28 BR BRPI0307816A patent/BRPI0307816B8/pt not_active IP Right Cessation
- 2003-05-28 DE DE60331920T patent/DE60331920D1/de not_active Expired - Lifetime
- 2003-05-28 DK DK03731404.4T patent/DK1530459T3/da active
- 2003-05-28 WO PCT/US2003/016732 patent/WO2003101383A2/en not_active Ceased
- 2003-05-28 EP EP03731404A patent/EP1530459B1/de not_active Revoked
- 2003-05-28 AU AU2003240808A patent/AU2003240808B2/en not_active Expired
- 2003-05-28 ES ES03731404T patent/ES2343790T3/es not_active Expired - Lifetime
- 2003-05-28 SI SI200331808T patent/SI1530459T1/sl unknown
2006
- 2006-05-26 BR BRC10307816A patent/BRPI0307816F1/pt unknown
2010
- 2010-06-11 CY CY20101100516T patent/CY1110184T1/el unknown
- 2010-09-30 JP JP2010221628A patent/JP5334937B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
SI1530459T1 (sl)	2010-08-31
CN1638745A (zh)	2005-07-13
JP2006516111A (ja)	2006-06-22
JP5334937B2 (ja)	2013-11-06
BRPI0307816F1 (pt)	2022-02-15
DE60331920D1 (de)	2010-05-12
BRPI0307816B8 (pt)	2021-05-25
BR0307816C1 (pt)	2006-09-19
HK1079421A1 (en)	2006-04-07
JP2010280739A (ja)	2010-12-16
MXPA04006054A (es)	2004-09-27
ES2343790T3 (es)	2010-08-10
DK1530459T3 (da)	2010-07-19
JP4718170B2 (ja)	2011-07-06
EP1530459A2 (de)	2005-05-18
AU2003240808B2 (en)	2008-05-08
EP1530459B1 (de)	2010-03-31
BR0307816A (pt)	2005-08-02
WO2003101383A3 (en)	2004-09-30
BRPI0307816B1 (pt)	2018-03-06
AU2003240808A1 (en)	2003-12-19
PT1530459E (pt)	2010-05-20
CN1287794C (zh)	2006-12-06
EP1530459A4 (de)	2007-08-22
WO2003101383A2 (en)	2003-12-11
CY1110184T1 (el)	2015-01-14

Similar Documents

Publication	Publication Date	Title
RU2356547C2 (ru)	2009-05-27	Способы лечения рака с использованием ингибиторов hdac
CY1110184T1 (el)	2015-01-14	Φαρμακευτικη συνθεση για μαλακες καψουλες για χορηγηση απο το στομα η οποια περιεχει βινορελβινη και μεθοδος θεραπειας
ES2180646T3 (es)	2003-02-16	Formulaciones liquidas orales de alendronato.
NO20062504L (no)	2006-07-21	Sammensetninger og doseringsformer for forbedret absorpsjon
CA2434484A1 (en)	2002-07-25	Compositions comprising ibuprofen and diphenhydramine to treat pain-associated sleep disturbances
EA200601253A1 (ru)	2006-12-29	Преимущественно линейная шипучая лекарственная форма фентанила для перорального применения и способы введения
EP2444072A3 (de)	2014-05-07	Nichtmukoadhäsive Filmdosierungsformen
JO3404B1 (ar)	2019-10-20	تركيبة صيدلانية سائلة تحتوي على مشتقات اريثروبويتين
DE50203456D1 (de)	2005-07-28	Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
RU2010147287A (ru)	2012-05-27	Комбинированная композиция
EP1365749A4 (de)	2005-09-07	Prozess zur herstellung von pharmazeutischen zusammensetzungen zur verwendung mit weichgelatine formulierungen
NO20055880L (no)	2005-12-28	Memantin orale doseringsformer
RU2010109359A (ru)	2011-10-20	Азитромицин для лечения кожных заболеваний
RU2007103306A (ru)	2008-09-10	Композиции на основе ризедроната и способы их применения
CO5640120A2 (es)	2006-05-31	Formulacion y metodods para el tratamiento de trombocitemia
HN2001000038A (es)	2005-03-23	Sistema de administracion oral controlada para la ingestion diaria de ciprofloxacina
MXPA04004907A (es)	2004-07-30	Composiciones de acetaminofen.
EA200600377A1 (ru)	2006-08-25	Новая композиция
ATE283036T1 (de)	2004-12-15	Pharmazeutische zusammensetzung mit gesteuerter freigabe enthaltend midodrin und/oder desglymidodrin
JP2012041314A5 (de)	2013-09-12
KR20060126555A (ko)	2006-12-07	피부학적 연질 겔 조성물
SE0102887D0 (sv)	2001-08-29	New formulation
WO2023150579A3 (en)	2023-10-19	Pharmaceutical formulations containing nalbuphine
CA2388431A1 (en)	2003-11-30	Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
RU2002129356A (ru)	2004-03-27	Комбинация лекарственных средств для лечения головной боли, содержащая нестероидное противовоспалительное лекарственное средство

Legal Events

Date

Code

Title

Description

2010-09-15

UEP

Publication of translation of european patent specification

Ref document number: 1530459

Country of ref document: EP